Year: 2025
Type: article
Abstract: The introduction of the Qdenga® dengue vaccine presents both opportunities and challenges. Debate regarding efficacy, safety, and potential risks for dengue-naïve individuals continues. With varying international guidelines and evolving evidence, advising travellers requires detailed risk assessment, up-to-date evidence based decisions, and clear communication.
Source: Journal of Travel Medicine
DOI: 10.1093/jtm/taaf023
Authors: Rachael Fletcher, Samia Richards-Zoubir, Imogen Koopmans, Catherine C Smith, Philip Veal, Dipti Patel
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,605
OpenAlex ID: W4408269633